N-{3-Oxo-7-[4-(3-m-tolyl-ureido)-phenyl]-2,3-dihydro-1H-isoindol-4-yl}-nicotinamide

ID: ALA184274

Chembl Id: CHEMBL184274

PubChem CID: 5329912

Max Phase: Preclinical

Molecular Formula: C28H23N5O3

Molecular Weight: 477.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(NC(=O)Nc2ccc(-c3ccc(NC(=O)c4cccnc4)c4c3CNC4=O)cc2)c1

Standard InChI:  InChI=1S/C28H23N5O3/c1-17-4-2-6-21(14-17)32-28(36)31-20-9-7-18(8-10-20)22-11-12-24(25-23(22)16-30-27(25)35)33-26(34)19-5-3-13-29-15-19/h2-15H,16H2,1H3,(H,30,35)(H,33,34)(H2,31,32,36)

Standard InChI Key:  WJRNKVIXFNDUOA-UHFFFAOYSA-N

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 and 2 (Flt-1 and KDR) (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT4 Tclin Vascular endothelial growth factor receptor 2 and 3 (KDR and Flt-4) (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin VEGF-receptor 2 and stem cell growth factor receptor (KDR and KIT) (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 and tyrosine-protein kinase TIE-2 (KDR and TIE2) (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin VEGF-receptor 2 and PDGF-receptor beta (KDR and PDGFR beta) (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin VEGF-receptor 2 and tyrosine-protein kinase SRC (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 477.52Molecular Weight (Monoisotopic): 477.1801AlogP: 5.20#Rotatable Bonds: 5
Polar Surface Area: 112.22Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.51CX Basic pKa: 3.51CX LogP: 4.63CX LogD: 4.63
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.32Np Likeness Score: -1.04

References

1. Curtin ML, Frey RR, Heyman HR, Sarris KA, Steinman DH, Holmes JH, Bousquet PF, Cunha GA, Moskey MD, Ahmed AA, Pease LJ, Glaser KB, Stewart KD, Davidsen SK, Michaelides MR..  (2004)  Isoindolinone ureas: a novel class of KDR kinase inhibitors.,  14  (17): [PMID:15357981] [10.1016/j.bmcl.2004.06.041]

Source